Moreover, positive associations between DCAF7 and TMB, MSI or NEO in several cancers suggest that DCAF7 may also influence the antigenic landscape, further modulating anti‐tumour immunity and potential treatment response. The gene discussed is DCAF7; the disease is cancer.